RUC-4 compound: Clinical Trials

2 trials of RUC-4 compound, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow RUC-4 compound: new trials by email Literature Review of RUC-4 compound trials Research Report on RUC-4 compound

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction
RUC-4 Compound - Coronary Disease, Myocardial Infarction
Phase 2CompletedCeleCor Therapeutics272020-06-022021-02-03
A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4
RUC-4 Compound - Coronary Disease
Phase 1CompletedCeleCor Therapeutics442019-02-182024-08-27

Conditions studied

Coronary Disease (2)  ·  Heart Diseases (1)  ·  Myocardial Infarction (1)  ·  ST Elevation Myocardial Infarction (1)  ·  Vascular Diseases (1)

Sponsors

CeleCor Therapeutics (2)

Countries

Netherlands (1)  ·  United States (1)

Results publications

PMID 32844723